Search Within

Rona Denit Yaeger

Formats
  1. Meeting Abstract (166)
  2. Journal Article (143)
  3. Review (7)
  4. Editorial (6)
  5. Research Letter (4)
  6. Book Section (1)
  7. Correspondence (1)
  8. Guidelines (1)
Groups
  1. Department of Medicine (329)
  2. Gastrointestinal Oncology Service (329)
  3. Solid Tumor Oncology Division (329)
  4. Center for Pancreatic Cancer Research (136)
  5. GSK Faculty (134)
  6. Department of Pathology and Laboratory Medicine (125)

More Groups

People
  1. Andrea Cercek Hanjis (95)
  2. Leonard Saltz (81)
  3. Jinru Shia (76)
  4. Martin Weiser (64)
  5. Zsofia Stadler (62)
  6. Julio Garcia Aguilar (61)

More People

Years
  1. 2025 (29)
  2. 2024 (41)
  3. 2023 (37)
  4. 2022 (39)
  5. 2021 (36)
  6. 2020 (28)

More Years

Publications
  1. Journal of Clinical Oncology (101)
  2. Annals of Oncology (37)
  3. Clinical Cancer Research (17)
  4. Cancer Research (15)
  5. Cancer Discovery (14)
  6. Nature Medicine (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (111)
  2. American Association for Cancer Research (51)
  3. Oxford University Press (48)
  4. Nature Publishing Group (26)
  5. Elsevier Inc. (19)
  6. Springer (10)

More Publishers

Results (329)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Atypical RAS mutations in metastatic colorectal cancer
    Journal Article

    Pietrantonio, F.; Yaeger, R.; Schrock, A. B.; Randon, G.; Romero-Cordoba, S.; Rossini, D.; Fucà, G.; Ross, J. S.; Kotani, D.; Madison, R.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • BEACON: A randomised, phase 3 study of encorafenib and cetuximab +/- binimetinib vs. choice of either irinotecan or FOLFIRI plus cetuximab in BRAF V600E-mutant metastatic colorectal cancer patients
    Meeting Abstract

    Wasan, H.; Arkenau, T.; Braun, M.; Samuel, L.; Graham, J.; Kopetz, S.; Grothey, A.; Van Cutsem, E.; Yaeger, R.; Yoshino, T.; more...
    British Journal of Cancer (2019)

    Fulltext@MSK | Save
  • Response to anti-EGFR therapy in patients with BRAF non-V600–mutant metastatic colorectal cancer
    Journal Article

    Yaeger, R.; Kotani, D.; Mondaca, S.; Parikh, A. R.; Bando, H.; Van Seventer, E. E.; Taniguchi, H.; Zhao, H.; Thant, C. N.; de Stanchina, E.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Molecular characteristics, immunophenotype, and immune checkpoint inhibitor response in BRAF non-V600 mutant lung cancers
    Meeting Abstract

    Offin, M.; Pak, T.; Mondaca, S.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Wu, S.; Kris, M.; Paik, P.; Riely, G.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • False retained mismatch repair protein expression in microsatellite instability-high cancers is associated with missense mutations in mismatch repair genes
    Meeting Abstract

    Rana, S.; Stadler, Z.; Schwark, A.; Yaeger, R.; Middha, S.; Shia, J.; Zehir, A.; Hechtman, J.
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save
  • BEACON CRC: A randomized, 3-Arm, phase 3 study of encorafenib (ENCO) and cetuximab (CETUX) with or without binimetinib (BINI) versus choice of either irinotecan or FOLFIRI plus cetuximab in BRAF V600E-mutant metastatic colorectal cancer
    Meeting Abstract

    Desai, J.; Kopetz, S.; Grothey, A.; Van Cutsem, E.; Yaeger, R.; Wasan, H.; Yoshino, T.; Ciardello, F.; Gollerkeri, A.; Maharry, K.; more...
    Asia-Pacific Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Encorafenib plus cetuximab with or without binimetinib for BRAF V600E-mutant metastatic colorectal cancer: Expanded results from a randomized, 3-arm, phase III study vs the choice of either irinotecan or FOLFIRI plus cetuximab (BEACON CRC)
    Meeting Abstract

    Tabernero, J.; Grothey, A.; Van Cutsem, E.; Yaeger, R.; Wasan, H.; Yoshino, T.; Desai, J.; Ciardiello, F.; Loupakis, F.; Sang Hong, Y.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer
    Journal Article

    Kopetz, S.; Grothey, A.; Yaeger, R.; Van Cutsem, E.; Desai, J.; Yoshino, T.; Wasan, H.; Ciardiello, F.; Loupakis, F.; Hong, Y. S.; more...
    New England Journal of Medicine (2019)

    Fulltext@MSK | Save
  • Contemporary validation of a nomogram predicting colon cancer recurrence, revealing all-stageimproved outcomes
    Journal Article

    Konishi, T.; Shimada, Y.; Hsu, M.; Wei, I. H.; Pappou, E.; Smith, J. J.; Nash, G. M.; Guillem, J. G.; Paty, P. B.; Garcia-Aguilar, J.; more...
    JNCI Cancer Spectrum (2019)

    Fulltext@MSK | Save
  • Genomic stratification beyond Ras/B-Raf in colorectal liver metastasis patients treated with hepatic arterial infusion
    Journal Article

    Smith, J. J.; Chatila, W. K.; Sanchez-Vega, F.; Datta, J.; Connell, L. C.; Szeglin, B. C.; Basunia, A.; Boucher, T. M.; Hauser, H.; Wasserman, I.; more...
    Cancer Medicine (2019)

    Fulltext@MSK | Save